Pharmicell Co., Ltd. (KRX: 005690)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,250.00
+270.00 (3.38%)
Dec 20, 2024, 3:30 PM KST

Pharmicell Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2013 FY 2012 FY 2011 FY 2010 FY 2009 2008 - 2005
Period Ending
Dec '24 Dec '13 Dec '12 Dec '11 Dec '10 Dec '09 2008 - 2005
Market Capitalization
495,033164,023213,530370,682173,37575,442
Upgrade
Market Cap Growth
-5.97%-23.19%-42.40%113.80%129.81%169.18%
Upgrade
Enterprise Value
159,109172,343219,632376,638176,42472,037
Upgrade
Last Close Price
8250.003780.005100.0010522.257190.993732.33
Upgrade
PS Ratio
15.034.9119.2236.0524.0210.49
Upgrade
PB Ratio
4.421.992.104.4817.505.47
Upgrade
P/TBV Ratio
3.183.443.276.6117.595.52
Upgrade
EV/Sales Ratio
6.645.1619.7736.6324.4410.02
Upgrade
Debt / Equity Ratio
0.140.110.270.181.400.63
Upgrade
Asset Turnover
0.210.280.090.160.270.36
Upgrade
Inventory Turnover
5.055.132.655.224.844.81
Upgrade
Quick Ratio
1.050.680.890.730.704.77
Upgrade
Current Ratio
1.341.081.070.910.855.41
Upgrade
Return on Equity (ROE)
-29.25%-27.94%-19.14%-39.23%-100.35%-39.62%
Upgrade
Return on Assets (ROA)
-4.98%-4.16%-7.50%-14.69%-24.61%-7.89%
Upgrade
Return on Capital (ROIC)
-5.33%-4.46%-7.85%-15.78%-28.28%-8.58%
Upgrade
Earnings Yield
-7.44%-15.67%-8.26%-4.90%-6.84%-5.24%
Upgrade
FCF Yield
-1.58%-1.93%-6.72%-4.54%-5.16%-7.77%
Upgrade
Buyback Yield / Dilution
-7.56%-11.91%-44.48%-1161.85%86.50%8.16%
Upgrade
Total Shareholder Return
-7.56%-11.91%-44.48%-1161.85%86.50%8.16%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.